Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

10-HYDROXYCAMPTOTHECIN for Therapeutic embolisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 19 adverse event reports in the FDA FAERS database where 10-HYDROXYCAMPTOTHECIN was used for Therapeutic embolisation.

Most Reported Side Effects for 10-HYDROXYCAMPTOTHECIN

Side Effect Reports % Deaths Hosp.
Device use issue 20 60.6% 4 0
Off label use 20 60.6% 4 0
Post embolisation syndrome 20 60.6% 4 0

Other Indications for 10-HYDROXYCAMPTOTHECIN

Hepatocellular carcinoma (12)

Other Drugs Used for Therapeutic embolisation

ETHIODIZED OIL (309) ENBUCRILATE (61) DOXORUBICIN (32) EPIRUBICIN (26) GELATIN (23) IODIZED OIL (20) UNSPECIFIED INGREDIENT (11) CISPLATIN (10) DEVICE (9) IODIXANOL (9)

Related Pages

10-HYDROXYCAMPTOTHECIN Full Profile All Therapeutic embolisation Drugs 10-HYDROXYCAMPTOTHECIN Demographics 10-HYDROXYCAMPTOTHECIN Timeline